Results 71 to 80 of about 17,861,189 (258)
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Bevacizumab (BEV) combined with standard chemotherapy with carboplatin and paclitaxel (CP) as the front-line treatment for newly diagnosed advanced-stage epithelial ovarian cancer (EOC) is a promising treatment option.
Kanyarat Katanyoo +2 more
doaj +1 more source
Health-adjusted life expectancy of the British population [PDF]
In this article, changes in the quality of health-adjusted life expectancy of the British population between 1991 and 1998 are analysed. It is found that at all given age levels, life expectancy increased during this period.
Groot, W. +7 more
core +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Background: Cost-effectiveness analysis involves the comparison of the incremental cost-effectiveness ratio of a new technology, which is more costly than existing alternatives, with the cost-effectiveness threshold.
Karl Claxton +8 more
doaj +1 more source
Willingness to pay per quality-adjusted life year per gross domestic product per capita by country.
Willingness to pay per quality-adjusted life year per gross domestic product per capita by country.
Klas Göran Sahlen (17935584) +5 more
core +1 more source
We explored covariates of the quality of life (QOL) in non- small-cell lung cancer (NSCLC) patients and made a comparison with healthy controls. We assessed the QOL of 220 consecutive NSCLC patients at a university hospital. The QOL data were measured by
李俊賢;張郁瑩;李元麒;楊志新;劉紹興;劉邦祥;王榮德 +1 more
core +1 more source
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
Global economic differences in modern glioblastoma care – a systematic review
Purpose Glioblastoma (GBM) is the most aggressive form of primary brain cancer and is associated with poor overall survival and expensive, resource intensive treatments.
Reuben Christopher +5 more
doaj +1 more source
Assessment of cost-effectiveness threshold using a double-bounded dichotomous choice model
Objectives: Willingness to pay (WTP) for one quality-adjusted life year (QALY) is highly variable according to survey methodology and can change over time, even within the same population.
Taito Kitano, Shinya Tsuzuki
doaj +1 more source

